COSCIENS Biopharma Inc (CSCI)

[PJO]

Another news story via BIOPHARMA 12/15/15

Shares of Aeterna Zentaris Inc. (NASDAQ:AEZS) shows upbeat performance increased 9.28% to end at $4.83. AstraZeneca reported that it was in talks that might lead to the takeover of privately held biotech firm Acerta Pharma, a possible $5B -plus contract deinked to build up its cancer drug portfolio.
AstraZeneca confirms that it is exploring potential strategic options with Acerta Pharma BV. There can be no certainty that any transaction will ultimately be entered into, or as to the terms of any transaction,” it stated in a brief statement. Credit Suisse analysts stated acalabrutinib’s considerable potential could also encourage other potential buyers. “If Acerta is open to a transaction, we would expect important interest from multiple other offerders,” they stated in a note. Force behind Aeterna Zentaris Inc. bullish run in this report?